MAP4K4 and cancer: Following Wright et al.’s initial report on its broad expression in 40 tumor cell lines from a National Cancer Institute human tumor panel16, subsequent studies have shown that MAP4K4 is highly overexpressed in various types of cancer, including hepatocellular carcinoma17, colorectal cancer18, lung cancer19,20, prostate cancer21, and pancreatic cancer22.